Companies · Healthtech

Stroma Medical Corp

Irvine · Healthtech · refined from filed group “Other Technology

Diligence memoA one-page analyst read on Stroma Medical Corp — recommendation, valuation, rhythm, risks.
$43.0M
Total raised · real
2
Rounds
11.7×
Latest step-up
Top 12%
Sector rank · raised
Series B
Latest stage · inferred · Wed Mar 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Stroma Medical Corp looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 1.72× the median modeled value of Series B Healthtech companies in 2019–2021 (56 peers) — value vs value, same stage and era.
Dormant
  • Last raise 5.3 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Stroma Medical Corp is one of 2138 Healthtech companies tracked from Irvine. By capital raised it ranks in the upper tier (ahead of 89% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
144
Investors (latest)
2021-03-31
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeed · 2012-05-01 Raised $3.6M (real) Modeled valuation $99M (est)$3.6M$99MSeed2012Seed · 2012-05-01 Raised $3.4M (real) Modeled valuation $93M (est)$3.4M$93MSeed2012Series B · 2021-03-31 Raised $39M (real) Modeled valuation $768M (est)$39M$768MSeries B2021+$3.4M+$39MCumulative $46M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$3.6M · 2012
Seed extension$3.4M · 2012
Series B$39.4M · 2021no Series A on file

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.

Modeled valuation trajectory
$767.6M
Base estimate est.
$92.7M
Conservative case
$2.6B
Upside case
$219.1M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Seed · modeled $99.1M · 2012-05-012012Seed · modeled $93.4M · 2012-05-01Series B · modeled $767.6M · 2021-03-312021
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.38×/yr
Annual markup
1.67×/yr upside case
5.3 yr
Elapsed time used
5.3 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
53 mo
Avg between rounds
$4.8M/yr
Capital velocity
14.2 yr
On record since
2012
First round
3
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 9.6× above median
This company$43.0M
Sector median$4.5M
Latest round — vs other Series B rounds in sector (real $, this stage) 2.2× above median
This company$39.4M
Sector median$18.3M
Modeled value — vs sector median (estimate, all stages) 23× above median
This company$767.6M
Sector median$33.8M

Raised more than 89% of sector peers (real $). Modeled value above 96% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #4 of 56.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0M$1.0BCapital raised (log)Solera Health, Inc. · Series B Raised $79.1M · modeled $935.6M (est)Icebreaker Health, Inc. · Series B Raised $51.5M · modeled $890.1M (est)Buoy Health, Inc. · Series B Raised $66.7M · modeled $837.4M (est)HealthJoy, Inc. · Series B Raised $45.5M · modeled $743.5M (est)Appriss Health Holdings, Inc. · Series B Raised $38.1M · modeled $718.0M (est)Superconductive Health, Inc. · Series B Raised $61.0M · modeled $717.0M (est)Wheel Health, Inc. · Series B Raised $36.7M · modeled $686.1M (est)Mindoula Health, Inc. · Series B Raised $30.7M · modeled $663.2M (est)Flowonix Medical Inc · Series B Raised $104.6M · modeled $656.8M (est)Sirona Medical, Inc. · Series B Raised $53.0M · modeled $638.3M (est)HealthPlan One Holdings, Inc. · Series B Raised $28.6M · modeled $621.6M (est)Stroma Medical Corp (this company) Raised $43.0M · modeled $767.6M (est)Stroma Medical Corp
CompanyStageRaised · realValue · estvs peer med.
Solera Health, Inc.Series B$79.1M$935.6M2.09×
Icebreaker Health, Inc.Series B$51.5M$890.1M1.99×
Buoy Health, Inc.Series B$66.7M$837.4M1.87×
Stroma Medical Corp this companySeries B$43.0M$767.6M1.72×
HealthJoy, Inc.Series B$45.5M$743.5M1.66×
Appriss Health Holdings, Inc.Series B$38.1M$718.0M1.61×
Superconductive Health, Inc.Series B$61.0M$717.0M1.60×
Wheel Health, Inc.Series B$36.7M$686.1M1.53×
Mindoula Health, Inc.Series B$30.7M$663.2M1.48×
Flowonix Medical IncSeries B$104.6M$656.8M1.47×
Sirona Medical, Inc.Series B$53.0M$638.3M1.43×
HealthPlan One Holdings, Inc.Series B$28.6M$621.6M1.39×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$3.6M2012-05-01$17.9M$99.1M85%
Seed$3.4M2012-05-01$16.8M$93.4M85%
Series B$39.4M2021-03-31$219.1M$767.6M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$3.6M2012-05-01
    • First recorded raise — entered as Seed.
    • 37 investors on this round.
  2. Seed$3.4M2012-05-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 36 investors on this round.
  3. Series B$39.4M2021-03-31
    • Raised again after 107 mo — slower than the ~14 mo sector norm.
    • Round 11.7× larger than the prior — scaling up.
    • 144 investors on this round.
Intelligence
2025 ~Q3
Modeled next raise · ~53mo cadence
$118.3M
Modeled next size est.range $76.9M$189.3M
11.7×
Last step-up
$4.8M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
J. Andy Corley4 other2012-05
AFSHIN NADERSHAHI1 other2021-03
Edward Peterson1 other2012-05
J Andrew Corley1 other2021-03
Baseer Khan2021-03
Bruce Andy Feuchter2012-05
Douglas Daniels2012-05
Gregg Homer2012-05
Stephen Slade2021-03
Registry & provenance

Stroma Medical Corp is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1618810
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Surface Ophthalmics, Inc.Other Health CareSeries B$40.1M$422.4Mnetwork2 shared operators · same stage
FirstHand Health, Inc.HealthtechSeries B$42.9M$302.8Msame sector · same stage
Meru Health Holding Inc.HealthtechSeries B$42.4M$452.7Msame sector · same stage
Upperline Health, Inc.HealthtechSeries B$43.8M$347.7Msame sector · same stage
Recuro Health, Inc.HealthtechSeries B$44.2M$340.0Msame sector · same stage
Atropos Health IncHealthtechSeries B$44.3M$232.5Msame sector · same stage
OtoNexus Medical Technologies, Inc.HealthtechSeries B$44.5M$151.7Msame sector · same stage
Elligo Health Research, Inc.HealthtechSeries B$41.5M$495.7Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Charta Health, Inc.HealthtechSeries B$148.8M88%
SRA Health, Inc.HealthtechSeed$6.8M88%
Palmera Medical, Inc.HealthtechSeries A$95.9M87%
Structural Health Systems, Inc.HealthtechSeed$80.9M86%
Healthe, Inc.HealthtechSeries B$465.2M85%
Leda Health CorpHealthtechSeries A$112.1M85%
Visana Health, Inc.HealthtechSeries B$113.2M85%
Stax Health, Inc.HealthtechSeed$41.3M85%
Frequently asked
How much funding has Stroma Medical Corp raised?
Stroma Medical Corp has raised approximately $43.0M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Stroma Medical Corp's estimated valuation?
Provath's modeled valuation for Stroma Medical Corp is approximately $767.6M (modeled range $92.7M–$2.6B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Stroma Medical Corp at?
Stroma Medical Corp's latest modeled financing stage is Series B. Its most recent recorded round closed around Wed Mar 31.
What does Stroma Medical Corp do and where is it based?
Stroma Medical Corp operates in the Healthtech sector, based in Irvine.
Explore related

See where Stroma Medical Corp sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Stroma Medical Corp, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.